Successful SARS-CoV-2 mRNA Vaccination Program in Allogeneic Hematopoietic Stem Cell Transplant Recipients—A Retrospective Single-Center Analysis

(1) Background: mRNA COVID-19 vaccines are effective but show varied efficacy in immunocompromised patients, including allogeneic hematopoietic stem cell transplant (HSCT) recipients. (2) Methods: A retrospective study on 167 HSCT recipients assessed humoral response to two mRNA vaccine doses, using...

Descripción completa

Detalles Bibliográficos
Autores principales: Nikoloudis, Alexander, Neumann, Ines Julia, Buxhofer-Ausch, Veronika, Machherndl-Spandl, Sigrid, Binder, Michaela, Kaynak, Emine, Milanov, Robert, Nocker, Stefanie, Stiefel, Olga, Strassl, Irene, Wipplinger, Dagmar, Moyses, Margarete, Kerschner, Heidrun, Apfalter, Petra, Girschikofsky, Michael, Petzer, Andreas, Weltermann, Ansgar, Clausen, Johannes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611175/
https://www.ncbi.nlm.nih.gov/pubmed/37896938
http://dx.doi.org/10.3390/vaccines11101534

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611175/
https://www.ncbi.nlm.nih.gov/pubmed/37896938
http://dx.doi.org/10.3390/vaccines11101534

Ejemplares similares